Home » Topics » Regulatory » Patents

Patents
RSS

Angiotensin II antagonists described by Sankyo

June 28, 1996

5-lipoxygenase and cyclooxygenase inhibitors from Abbott

June 28, 1996

Abbott discloses 5-lipoxygenase inhibitors

June 28, 1996

Leukotriene biosynthesis inhibitors from Merck Frosst

June 28, 1996

Suntory describes metabotropic glutamate antagonists

June 28, 1996

RPR reports glutamate antagonists

June 28, 1996

NMDA antagonists synthesized by Hoechst Marion Roussel

June 28, 1996

Protein kinase inhibitors reported by Cephalon

June 28, 1996

Brain monoamine partial agonists/antagonists claimed by Neurogen

June 28, 1996

Apolipoprotein B synthesis inhibitors reported

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
ASH 2025: Tec-dara shines on ‘functional cure’ Majestec-3 MM data
BioWorld
Impressive results of a potential second-line combination treatment for multiple myeloma from the Majestec-3 trial of teclistamab plus daratumumab raised eyebrows...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...